Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair

Abstract Hepatorenal dysfunction is a strong risk factor in patients with heart failure (HF). We investigated the prognostic significance of hepatorenal dysfunction in 172 consecutive patients undergoing transcatheter tricuspid valve repair (TTVR). The model for end-stage liver disease excluding int...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tetsu Tanaka, Refik Kavsur, Atsushi Sugiura, Johanna Vogelhuber, Can Öztürk, Marcel Weber, Vedat Tiyerili, Sebastian Zimmer, Georg Nickenig, Marc Ulrich Becher
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9e8e6c05aadc46b7a938c6d9c4f8fd52
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9e8e6c05aadc46b7a938c6d9c4f8fd52
record_format dspace
spelling oai:doaj.org-article:9e8e6c05aadc46b7a938c6d9c4f8fd522021-12-02T18:30:51ZPrognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair10.1038/s41598-021-93952-92045-2322https://doaj.org/article/9e8e6c05aadc46b7a938c6d9c4f8fd522021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93952-9https://doaj.org/toc/2045-2322Abstract Hepatorenal dysfunction is a strong risk factor in patients with heart failure (HF). We investigated the prognostic significance of hepatorenal dysfunction in 172 consecutive patients undergoing transcatheter tricuspid valve repair (TTVR). The model for end-stage liver disease excluding international normalized ratio (MELD-XI) score was calculated as 5.11 × ln(serum total bilirubin [mg/dl]) + 11.76 × ln(serum creatinine [mg/dl]) + 9.44. Patients were stratified into two groups: high (≥ 14) or low (< 14) MELD-XI score, according to the best cut-off value to predict a one-year composite outcome consisting of all-cause mortality and HF hospitalization. Compared to patients with low MELD-XI score (n = 121), patients with high MELD-XI score (n = 51) had a higher incidence of the composite outcome (47.1% vs. 17.4%; p < 0.0001). In the multivariable analysis, the MELD-XI score was an independent predictor of the composite outcome (adjusted hazard ratio: 1.12; 95% confidence interval [CI] 1.05–1.19; p = 0.0003). In addition, post-procedural TR < 3 + after TTVR was independently associated with a reduction in MELD-XI score six months after TTVR (adjusted odds ratio: 3.37; 95% CI 1.09–10.40; p = 0.03). Thus, the MELD-XI score was associated with the risk of one-year composite outcome, consisting of mortality and HF hospitalization, after TTVR and may help the risk stratification in patients undergoing TTVR.Tetsu TanakaRefik KavsurAtsushi SugiuraJohanna VogelhuberCan ÖztürkMarcel WeberVedat TiyeriliSebastian ZimmerGeorg NickenigMarc Ulrich BecherNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tetsu Tanaka
Refik Kavsur
Atsushi Sugiura
Johanna Vogelhuber
Can Öztürk
Marcel Weber
Vedat Tiyerili
Sebastian Zimmer
Georg Nickenig
Marc Ulrich Becher
Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair
description Abstract Hepatorenal dysfunction is a strong risk factor in patients with heart failure (HF). We investigated the prognostic significance of hepatorenal dysfunction in 172 consecutive patients undergoing transcatheter tricuspid valve repair (TTVR). The model for end-stage liver disease excluding international normalized ratio (MELD-XI) score was calculated as 5.11 × ln(serum total bilirubin [mg/dl]) + 11.76 × ln(serum creatinine [mg/dl]) + 9.44. Patients were stratified into two groups: high (≥ 14) or low (< 14) MELD-XI score, according to the best cut-off value to predict a one-year composite outcome consisting of all-cause mortality and HF hospitalization. Compared to patients with low MELD-XI score (n = 121), patients with high MELD-XI score (n = 51) had a higher incidence of the composite outcome (47.1% vs. 17.4%; p < 0.0001). In the multivariable analysis, the MELD-XI score was an independent predictor of the composite outcome (adjusted hazard ratio: 1.12; 95% confidence interval [CI] 1.05–1.19; p = 0.0003). In addition, post-procedural TR < 3 + after TTVR was independently associated with a reduction in MELD-XI score six months after TTVR (adjusted odds ratio: 3.37; 95% CI 1.09–10.40; p = 0.03). Thus, the MELD-XI score was associated with the risk of one-year composite outcome, consisting of mortality and HF hospitalization, after TTVR and may help the risk stratification in patients undergoing TTVR.
format article
author Tetsu Tanaka
Refik Kavsur
Atsushi Sugiura
Johanna Vogelhuber
Can Öztürk
Marcel Weber
Vedat Tiyerili
Sebastian Zimmer
Georg Nickenig
Marc Ulrich Becher
author_facet Tetsu Tanaka
Refik Kavsur
Atsushi Sugiura
Johanna Vogelhuber
Can Öztürk
Marcel Weber
Vedat Tiyerili
Sebastian Zimmer
Georg Nickenig
Marc Ulrich Becher
author_sort Tetsu Tanaka
title Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair
title_short Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair
title_full Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair
title_fullStr Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair
title_full_unstemmed Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair
title_sort prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/9e8e6c05aadc46b7a938c6d9c4f8fd52
work_keys_str_mv AT tetsutanaka prognosticimpactofhepatorenalfunctioninpatientsundergoingtranscathetertricuspidvalverepair
AT refikkavsur prognosticimpactofhepatorenalfunctioninpatientsundergoingtranscathetertricuspidvalverepair
AT atsushisugiura prognosticimpactofhepatorenalfunctioninpatientsundergoingtranscathetertricuspidvalverepair
AT johannavogelhuber prognosticimpactofhepatorenalfunctioninpatientsundergoingtranscathetertricuspidvalverepair
AT canozturk prognosticimpactofhepatorenalfunctioninpatientsundergoingtranscathetertricuspidvalverepair
AT marcelweber prognosticimpactofhepatorenalfunctioninpatientsundergoingtranscathetertricuspidvalverepair
AT vedattiyerili prognosticimpactofhepatorenalfunctioninpatientsundergoingtranscathetertricuspidvalverepair
AT sebastianzimmer prognosticimpactofhepatorenalfunctioninpatientsundergoingtranscathetertricuspidvalverepair
AT georgnickenig prognosticimpactofhepatorenalfunctioninpatientsundergoingtranscathetertricuspidvalverepair
AT marculrichbecher prognosticimpactofhepatorenalfunctioninpatientsundergoingtranscathetertricuspidvalverepair
_version_ 1718377996627214336